Supply Chain | March 31, 2025
DKSH Technology acquires Korean life science firm MDxK
The acquisition of MDxK further strengthens the Business Unit’s position in the molecular diagnostics market
The acquisition of MDxK further strengthens the Business Unit’s position in the molecular diagnostics market
Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai
New facility will support plans to advance J&J’s portfolio and pipeline of transformational medicines for cancer, immune-mediated and neurological diseases
Indegene combines deep healthcare expertise with a digital-first approach to help pharma, biotech and medical device companies commercialize their products
Biocon Foundation has been steadfast in its mission to empower underserved communities through innovative healthcare solutions, education, and sustainable development initiatives
Amgen India investment totals $200 million through 2025
Richard A. Gonzalez to retire from the board of directors effective July 1, 2025
Pascal Villemagne has announced his intent to step down at the end of March 2025, to take on a new challenge in his professional career.
The change is reflective of the company’s evolving vision aimed at further strengthening its global presence and a commitment to providing innovative solutions in the API and CDMO space
Subscribe To Our Newsletter & Stay Updated
